Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis
Dysregulated cell–cell adhesion plays a critical role in epithelial cancer development. Studies of human and mouse cancers have indicated that loss of adhesion complexes known as adherens junctions contributes to tumor progression and metastasis. In contrast, little is known regarding the role of the related cell–cell adhesion junction, the desmosome, during cancer development. Studies analyzing expression of desmosome components during human cancer progression have yielded conflicting results, and therefore genetic studies using knockout mice to examine the functional consequence of desmosome inactivation for tumorigenesis are essential for elucidating the role of desmosomes in cancer development. Here, we investigate the consequences of desmosome loss for carcinogenesis by analyzing conditional knockout mice lacking Perp, a p53/p63 regulated gene that encodes an important component of desmosomes. Analysis of Perp-deficient mice in a UVB-induced squamous cell skin carcinoma model reveals that Perp ablation promotes both tumor initiation and progression. Tumor development is associated with inactivation of both of Perp's known functions, in apoptosis and cell–cell adhesion. Interestingly, Perp-deficient tumors exhibit widespread downregulation of desmosomal constituents while adherens junctions remain intact, suggesting that desmosome loss is a specific event important for tumorigenesis rather than a reflection of a general change in differentiation status. Similarly, human squamous cell carcinomas display loss of PERP expression with retention of adherens junctions components, indicating that this is a relevant stage of human cancer development. Using gene expression profiling, we show further that Perp loss induces a set of inflammation-related genes that could stimulate tumorigenesis. Together, these studies suggest that Perp-deficiency promotes cancer by enhancing cell survival, desmosome loss, and inflammation, and they highlight a fundamental role for Perp and desmosomes in tumor suppression. An understanding of the factors affecting cancer progression is important for ultimately improving the diagnosis, prognostication, and treatment of cancer.
Vyšlo v časopise:
Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis. PLoS Genet 6(10): e32767. doi:10.1371/journal.pgen.1001168
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1001168
Souhrn
Dysregulated cell–cell adhesion plays a critical role in epithelial cancer development. Studies of human and mouse cancers have indicated that loss of adhesion complexes known as adherens junctions contributes to tumor progression and metastasis. In contrast, little is known regarding the role of the related cell–cell adhesion junction, the desmosome, during cancer development. Studies analyzing expression of desmosome components during human cancer progression have yielded conflicting results, and therefore genetic studies using knockout mice to examine the functional consequence of desmosome inactivation for tumorigenesis are essential for elucidating the role of desmosomes in cancer development. Here, we investigate the consequences of desmosome loss for carcinogenesis by analyzing conditional knockout mice lacking Perp, a p53/p63 regulated gene that encodes an important component of desmosomes. Analysis of Perp-deficient mice in a UVB-induced squamous cell skin carcinoma model reveals that Perp ablation promotes both tumor initiation and progression. Tumor development is associated with inactivation of both of Perp's known functions, in apoptosis and cell–cell adhesion. Interestingly, Perp-deficient tumors exhibit widespread downregulation of desmosomal constituents while adherens junctions remain intact, suggesting that desmosome loss is a specific event important for tumorigenesis rather than a reflection of a general change in differentiation status. Similarly, human squamous cell carcinomas display loss of PERP expression with retention of adherens junctions components, indicating that this is a relevant stage of human cancer development. Using gene expression profiling, we show further that Perp loss induces a set of inflammation-related genes that could stimulate tumorigenesis. Together, these studies suggest that Perp-deficiency promotes cancer by enhancing cell survival, desmosome loss, and inflammation, and they highlight a fundamental role for Perp and desmosomes in tumor suppression. An understanding of the factors affecting cancer progression is important for ultimately improving the diagnosis, prognostication, and treatment of cancer.
Zdroje
1. CooperGM
1995 Oncogenes Boston Jones and Bartlett Publishers xv, 384
2. AlamM
RatnerD
2001 Cutaneous squamous-cell carcinoma. N Engl J Med 344 975 983
3. HunterKD
ParkinsonEK
HarrisonPR
2005 Profiling early head and neck cancer. Nat Rev Cancer 5 127 135
4. FuchsE
RaghavanS
2002 Getting under the skin of epidermal morphogenesis. Nat Rev Genet 3 199 209
5. GreenKJ
GaudryCA
2000 Are desmosomes more than tethers for intermediate filaments? Nat Rev Mol Cell Biol 1 208 216
6. YinT
GreenKJ
2004 Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 15 665 677
7. ChidgeyM
2002 Desmosomes and disease: an update. Histol Histopathol 17 1179 1192
8. NoseA
NagafuchiA
TakeichiM
1988 Expressed recombinant cadherins mediate cell sorting in model systems. Cell 54 993 1001
9. NagafuchiA
ShirayoshiY
OkazakiK
YasudaK
TakeichiM
1987 Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 329 341 343
10. OzawaM
BaribaultH
KemlerR
1989 The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8 1711 1717
11. RimmDL
KoslovER
KebriaeiP
CianciCD
MorrowJS
1995 Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci U S A 92 8813 8817
12. VleminckxK
VakaetLJr
MareelM
FiersW
van RoyF
1991 Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66 107 119
13. FrixenUH
BehrensJ
SachsM
EberleG
VossB
1991 E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113 173 185
14. BatlleE
SanchoE
FranciC
DominguezD
MonfarM
2000 The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2 84 89
15. MoodySE
PerezD
PanTC
SarkisianCJ
PortocarreroCP
2005 The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8 197 209
16. SchipperJH
FrixenUH
BehrensJ
UngerA
JahnkeK
1991 E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51 6328 6337
17. PerlAK
WilgenbusP
DahlU
SembH
ChristoforiG
1998 A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392 190 193
18. DerksenPW
LiuX
SaridinF
van der GuldenH
ZevenhovenJ
2006 Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10 437 449
19. DavisMA
ReynoldsAB
2006 Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. Dev Cell 10 21 31
20. Perez-MorenoM
SongW
PasolliHA
WilliamsSE
FuchsE
2008 Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer. Proc Natl Acad Sci U S A 105 15399 15404
21. VasioukhinV
BauerC
DegensteinL
WiseB
FuchsE
2001 Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 104 605 617
22. KobielakA
FuchsE
2006 Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc Natl Acad Sci U S A 103 2322 2327
23. ChitaevNA
TroyanovskySM
1997 Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J Cell Biol 138 193 201
24. TselepisC
ChidgeyM
NorthA
GarrodD
1998 Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci U S A 95 8064 8069
25. SyedSE
TrinnamanB
MartinS
MajorS
HutchinsonJ
2002 Molecular interactions between desmosomal cadherins. Biochem J 362 317 327
26. MathurM
GoodwinL
CowinP
1994 Interactions of the cytoplasmic domain of the desmosomal cadherin Dsg1 with plakoglobin. J Biol Chem 269 14075 14080
27. TroyanovskySM
TroyanovskyRB
EshkindLG
LeubeRE
FrankeWW
1994 Identification of amino acid sequence motifs in desmocollin, a desmosomal glycoprotein, that are required for plakoglobin binding and plaque formation. Proc Natl Acad Sci U S A 91 10790 10794
28. HatzfeldM
HaffnerC
SchulzeK
VinzensU
2000 The function of plakophilin 1 in desmosome assembly and actin filament organization. J Cell Biol 149 209 222
29. ChenX
BonneS
HatzfeldM
van RoyF
GreenKJ
2002 Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling. J Biol Chem 277 10512 10522
30. BonneS
GilbertB
HatzfeldM
ChenX
GreenKJ
2003 Defining desmosomal plakophilin-3 interactions. J Cell Biol 161 403 416
31. KowalczykAP
HatzfeldM
BornslaegerEA
KoppDS
BorgwardtJE
1999 The head domain of plakophilin-1 binds to desmoplakin and enhances its recruitment to desmosomes. Implications for cutaneous disease. J Biol Chem 274 18145 18148
32. KowalczykAP
BornslaegerEA
BorgwardtJE
PalkaHL
DhaliwalAS
1997 The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J Cell Biol 139 773 784
33. BornslaegerEA
CorcoranCM
StappenbeckTS
GreenKJ
1996 Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J Cell Biol 134 985 1001
34. GreenKJ
SimpsonCL
2007 Desmosomes: new perspectives on a classic. J Invest Dermatol 127 2499 2515
35. YashiroM
NishiokaN
HirakawaK
2006 Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer 42 2397 2403
36. RoepmanP
WesselsLF
KettelarijN
KemmerenP
MilesAJ
2005 An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37 182 186
37. PapagerakisS
ShabanaAH
PollockBH
PapagerakisP
DepondtJ
2009 Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer. Hum Pathol 40 1320 1329
38. DepondtJ
ShabanaAH
Florescu-ZorilaS
GehannoP
ForestN
1999 Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis. Eur J Oral Sci 107 183 193
39. FurukawaC
DaigoY
IshikawaN
KatoT
ItoT
2005 Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res 65 7102 7110
40. ChenYJ
ChangJT
LeeL
WangHM
LiaoCT
2007 DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene 26 467 476
41. KurzenH
MunzingI
HartschuhW
2003 Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol 30 621 630
42. AttardiLD
ReczekEE
CosmasC
DemiccoEG
McCurrachME
2000 PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14 704 718
43. IhrieRA
MarquesMR
NguyenBT
HornerJS
PapazogluC
2005 Perp is a p63-regulated gene essential for epithelial integrity. Cell 120 843 856
44. JiangW
AnanthaswamyHN
MullerHK
KripkeML
1999 p53 protects against skin cancer induction by UV-B radiation. Oncogene 18 4247 4253
45. IndraAK
LiM
BrocardJ
WarotX
BornertJM
2000 Targeted somatic mutagenesis in mouse epidermis. Horm Res 54 296 300
46. MetzgerD
LiM
ChambonP
2005 Targeted somatic mutagenesis in the mouse epidermis. Methods Mol Biol 289 329 340
47. IhrieRA
ReczekE
HornerJS
KhachatrianL
SageJ
2003 Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr Biol 13 1985 1990
48. HakemR
HakemA
DuncanGS
HendersonJT
WooM
1998 Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94 339 352
49. JozaN
SusinSA
DaugasE
StanfordWL
ChoSK
2001 Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410 549 554
50. ZieglerA
JonasonAS
LeffellDJ
SimonJA
SharmaHW
1994 Sunburn and p53 in the onset of skin cancer. Nature 372 773 776
51. BornslaegerEA
GodselLM
CorcoranCM
ParkJK
HatzfeldM
2001 Plakophilin 1 interferes with plakoglobin binding to desmoplakin, yet together with plakoglobin promotes clustering of desmosomal plaque complexes at cell-cell borders. J Cell Sci 114 727 738
52. KalluriR
WeinbergRA
2009 The basics of epithelial-mesenchymal transition. J Clin Invest 119 1420 1428
53. TusherVG
TibshiraniR
ChuG
2001 Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 5116 5121
54. BlumbergH
DinhH
TruebloodES
PretoriusJ
KuglerD
2007 Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 204 2603 2614
55. GebhardtC
NemethJ
AngelP
HessJ
2006 S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72 1622 1631
56. SalamaI
MalonePS
MihaimeedF
JonesJL
2008 A review of the S100 proteins in cancer. Eur J Surg Oncol 34 357 364
57. EurichK
SegawaM
Toei-ShimizuS
MizoguchiE
2009 Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells. World J Gastroenterol 15 5249 5259
58. BeiderK
AbrahamM
BeginM
WaldH
WeissID
2009 Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One 4 e5125 doi:10.1371/journal.pone.0005125
59. HasanL
MazzucchelliL
LiebiM
LisM
HungerRE
2006 Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing. J Immunol 176 6512 6522
60. PunjV
MattaH
SchamusS
YangT
ChangY
2009 Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation. Blood 113 5660 5668
61. Ben-BaruchA
2006 The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25 357 371
62. O'SheaJJ
MurrayPJ
2008 Cytokine signaling modules in inflammatory responses. Immunity 28 477 487
63. GrivennikovSI
GretenFR
KarinM
2010 Immunity, inflammation, and cancer. Cell 140 883 899
64. PinkusGS
PinkusJL
1991 Myeloperoxidase: a specific marker for myeloid cells in paraffin sections. Mod Pathol 4 733 741
65. RibattiD
VaccaA
NicoB
CrivellatoE
RoncaliL
2001 The role of mast cells in tumour angiogenesis. Br J Haematol 115 514 521
66. CoussensLM
RaymondWW
BergersG
Laig-WebsterM
BehrendtsenO
1999 Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13 1382 1397
67. Ch'ngS
WallisRA
YuanL
DavisPF
TanST
2006 Mast cells and cutaneous malignancies. Mod Pathol 19 149 159
68. MeiningerCJ
1995 Mast cells and tumor-associated angiogenesis. Chem Immunol 62 239 257
69. MaltbyS
KhazaieK
McNagnyKM
2009 Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 1796 19 26
70. BashkinP
RazinE
EldorA
VlodavskyI
1990 Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood 75 2204 2212
71. VlodavskyI
EldorA
Haimovitz-FriedmanA
MatznerY
Ishai-MichaeliR
1992 Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12 112 127
72. NavaP
LaukoetterMG
HopkinsAM
LaurO
Gerner-SmidtK
2007 Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell 18 4565 4578
73. DusekRL
GetsiosS
ChenF
ParkJK
AmargoEV
2006 The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem 281 3614 3624
74. NaikE
MichalakEM
VillungerA
AdamsJM
StrasserA
2007 Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J Cell Biol 176 415 424
75. AndreuP
JohanssonM
AffaraNI
PucciF
TanT
2010 FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 17 121 134
76. CuiW
FowlisDJ
BrysonS
DuffieE
IrelandH
1996 TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86 531 542
77. PierceAM
Schneider-BroussardR
Gimenez-ContiIB
RussellJL
ContiCJ
1999 E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol 19 6408 6414
78. MarquesMR
HornerJS
IhrieRA
BronsonRT
AttardiLD
2005 Mice lacking the p53/p63 target gene Perp are resistant to papilloma development. Cancer Res 65 6551 6556
79. KempCJ
DonehowerLA
BradleyA
BalmainA
1993 Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74 813 822
80. BenjaminCL
UllrichSE
KripkeML
AnanthaswamyHN
2008 p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem Photobiol 84 55 62
81. BruinsW
ZwartE
AttardiLD
IwakumaT
HoogervorstEM
2004 Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389. Mol Cell Biol 24 8884 8894
82. MelnikovaVO
AnanthaswamyHN
2005 Cellular and molecular events leading to the development of skin cancer. Mutat Res 571 91 106
83. LozanoG
ZambettiGP
2005 What have animal models taught us about the p53 pathway? J Pathol 205 206 220
84. HemannMT
ZilfouJT
ZhaoZ
BurgessDJ
HannonGJ
2004 Suppression of tumorigenesis by the p53 target PUMA. Proc Natl Acad Sci U S A 101 9333 9338
85. ArmstrongBK
KrickerA
2001 The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63 8 18
86. 2009 Detailed Guide: Esophagus Cancer. American Cancer Society
87. KashiwagiS
YashiroM
TakashimaT
NomuraS
NodaS
2010 Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer 103 249 255
88. MellLK
MeyerJJ
TretiakovaM
KhramtsovA
GongC
2004 Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Clin Can Res 10 5546 5553
89. LuthraR
WuTT
LuthraMG
IzzoJ
Lopez-AlvarezE
2006 Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24 259 267
90. HarradineKA
RiddK
SaunierEF
ClermontFF
Perez-LosadaJ
2009 Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients. Clin Cancer Res 15 5101 5107
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2010 Číslo 10
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Genome-Wide Identification of Targets and Function of Individual MicroRNAs in Mouse Embryonic Stem Cells
- Common Genetic Variants and Modification of Penetrance of -Associated Breast Cancer
- Allele-Specific Down-Regulation of Expression Induced by Retinoids Contributes to Climate Adaptations
- Simultaneous Disruption of Two DNA Polymerases, Polη and Polζ, in Avian DT40 Cells Unmasks the Role of Polη in Cellular Response to Various DNA Lesions